Maria Echavarria
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Maria Echavarria has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Anna De Benedetto
Department of Dermatology University of Rochester Medical Center Rochester New York USA
1 shared publication Anna M. Cheng
Morsani College of Medicine, University of South Florida, Tampa, FL, USA
1 shared publicationCarla C. Moodie
Department of Thoracic Oncology, Moffitt Cancer Center, 12902 USF Magnolia Dr., Suite FOB-1, Tampa, FL, USA
1 shared publication- Diana Montoya-Williams
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
1 shared publication - Diane Howell
Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, USA
1 shared publication Emily P. Ng
Morsani College of Medicine, University of South Florida, Tampa, FL, USA
1 shared publication
Latest Publications
- 5 July 2021
- Published by Wiley in Pediatric Dermatology
- Vol. 38 (4) , 879-882
Eruptive agminated nevi in a successfully treated Langerhans cell histiocytosis patient
A 7‐year‐old girl with a history of Langerhans cell histiocytosis (LCH), in remission, presented with the sudden appearance of multiple, agminated nevi. Skin biopsy revealed a benign junctional nevus, without recurrence of LCH. Subsequent immunohistochemical testing of both the skin and iliac wing biopsies demonstrated a BRAF V600E mutation. MAPK pathway mutations have been implicated in both LCH and nevogenesis.
- 5 July 2021
- Published by Wiley in Pediatric Dermatology
- Vol. 38 (4) , 879-882
Eruptive agminated nevi in a successfully treated Langerhans cell histiocytosis patient
A 7‐year‐old girl with a history of Langerhans cell histiocytosis (LCH), in remission, presented with the sudden appearance of multiple, agminated nevi. Skin biopsy revealed a benign junctional nevus, without recurrence of LCH. Subsequent immunohistochemical testing of both the skin and iliac wing biopsies demonstrated a BRAF V600E mutation. MAPK pathway mutations have been implicated in both LCH and nevogenesis.
- Open Access
- 1 May 2020
- Published by SAGE Publications in Journal of Women's Health
- Vol. 29 (5) , 647-655
Associations Between a Healthy Start Program Prenatal Risk Screening Tool and Adverse Birth Outcomes: A Study Using the Mother/Infant Dyad Screening Cohort
Background: Florida's Healthy Start Program is a statewide prenatal screening program that aims to identify pregnant women at risk of adverse birth outcomes. However, the effectiveness of this legislatively mandated prenatal risk screening tool in predicting poor birth outcomes is unknown. This study aimed to evaluate associations between risk factors self-reported on this screening tool and adverse birth outcomes. Materials and Methods: A 1-year retrospective birth cohort at a large academic referral center was created. Risk factors reported on the tool by mothers who had a preterm or low-birthweight (LBW) infant were compared with those reported by mothers who delivered full-term non-LBW infants in bivariate and multivariate analyses. All data were extracted from maternal or infant electronic health records. Results: The Mother/Infant Dyad Screening cohort consisted of 528 dyads. We identified two items on the screening tool that significantly associated with adverse birth outcomes, but which do not currently contribute to the total risk score used to identify women for referral to preventive social services. These items were feeling alone and thinking it was not a good time to be pregnant. Conclusions: Comprehensive prenatal risk screening is an underutilized strategy in medicine. Florida's mandatory self-reported, prenatal survey can identify women at risk for poor neonatal outcomes. A more nuanced understanding how women are interpreting survey items and a re-evaluation of scoring practices may allow the tool to better serve as a model for other programs seeking to identify pregnant women at risk of poor birth outcomes.
- 1 May 2020
- Published by SAGE Publications in Journal of Women's Health
- Vol. 29 (5) , 647-655
Open AccessAssociations Between a Healthy Start Program Prenatal Risk Screening Tool and Adverse Birth Outcomes: A Study Using the Mother/Infant Dyad Screening Cohort
Background: Florida's Healthy Start Program is a statewide prenatal screening program that aims to identify pregnant women at risk of adverse birth outcomes. However, the effectiveness of this legislatively mandated prenatal risk screening tool in predicting poor birth outcomes is unknown. This study aimed to evaluate associations between risk factors self-reported on this screening tool and adverse birth outcomes. Materials and Methods: A 1-year retrospective birth cohort at a large academic referral center was created. Risk factors reported on the tool by mothers who had a preterm or low-birthweight (LBW) infant were compared with those reported by mothers who delivered full-term non-LBW infants in bivariate and multivariate analyses. All data were extracted from maternal or infant electronic health records. Results: The Mother/Infant Dyad Screening cohort consisted of 528 dyads. We identified two items on the screening tool that significantly associated with adverse birth outcomes, but which do not currently contribute to the total risk score used to identify women for referral to preventive social services. These items were feeling alone and thinking it was not a good time to be pregnant. Conclusions: Comprehensive prenatal risk screening is an underutilized strategy in medicine. Florida's mandatory self-reported, prenatal survey can identify women at risk for poor neonatal outcomes. A more nuanced understanding how women are interpreting survey items and a re-evaluation of scoring practices may allow the tool to better serve as a model for other programs seeking to identify pregnant women at risk of poor birth outcomes.
- 1 December 2016
- Published by Elsevier in The American Journal of Surgery
- Vol. 212 (6) , 1175-1182
Comparison of pulmonary function tests and perioperative outcomes after robotic-assisted pulmonary lobectomy vs segmentectomy
- 1 December 2016
- Published by Elsevier in The American Journal of Surgery
- Vol. 212 (6) , 1175-1182
Comparison of pulmonary function tests and perioperative outcomes after robotic-assisted pulmonary lobectomy vs segmentectomy